References in periodicals archive ?
M2 PHARMA-September 17, 2013-Gentris introduces Affymetrix GeneChip human transcriptome array(C)2013 M2 COMMUNICATIONS
The Geneus and GeneChip platforms, GeneChip operating software (GCOS) and the GeneChip Command Console software (AGCC) have been combined to ensure the development of a seamless integration that enables bilateral communication between Geneus and the GeneChip microarray platform.
Santa Clara, CA) said that the Broad Institute (Cambridge, MA) of MIT and Harvard will use the Affymetrix GeneChip Mapping 500K Set for several groundbreaking genome-wide association studies in critical areas, including cancer, cardiovascular, metabolic and neuropsychiatric diseases.
Under a strategic relationship with Chinese life science company CapitalBio, Affymetrix GeneChip products will be sold in China through a service provider program.
The Broad Institute is using the GeneChip HT system to undertake large-scale genomic and genetics projects, including genome-wide SNP association studies to understand the genetics of complex disease, genome-wide RNA expression analyses to discover the molecular signatures of disease and drug response, and large-scale DNA resequencing for genetic studies of cancer.
has satisfied that goal with the development of the Affyrnetrlx GeneChip Scanner 3000 with AutoLoader.
The p53 GeneChip has been compared with direct sequencing for identifying p53 gene alterations in DNA extracted from frozen tissue of 108 ovarian cancers.
28 February 2011 - US medical technology company Affymetrix Inc (NASDAQ: AFFX) announced today the launch of its next-generation microRNA solution GeneChip miRNA 2.
The Geneus solution and GeneChip platforms, GeneChip Operating Software (GCOS), and the GeneChip Command Console Software (AGCC) have been combined to ensure the development of a seamless integration that enables bilateral communication between Geneus and the GeneChip microarray platform.
Santa Clara, CA) has granted Veridex, LLC, a Johnson & Johnson company, long-term and comprehensive access to its GeneChip technology to create and market in-vitro diagnostics for cancer.
Additionally, we plan to launch GeneChip brand sample labeling kits in the near future.
Two commercialized DNA array technologies are also discussed: the Flow-Thru[TM] chip from Gene Logic (Chapter 5) and the Affymetrix GeneChip, created using photolithography (Chapter 6).